KFDA to promote earlier commercialization of biodrugs

Published: 2002-12-02 06:59:00

Updated: 2002-12-02 06:59:00

The Korea Food and Drug Administration (KFDA) unveiled a plan to undertaken some research projects covering the license of biodrugs, safety of cell- and tissue-engineered drugs, and safety assessment of gene-related drugs so as to strengthen the competitiveness of biotechnology products and short...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK